Georges Hirth

1.8k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Georges Hirth is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Georges Hirth has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Physiology. Recurrent topics in Georges Hirth's work include Carbohydrate Chemistry and Synthesis (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Enzyme Catalysis and Immobilization (4 papers). Georges Hirth is often cited by papers focused on Carbohydrate Chemistry and Synthesis (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Enzyme Catalysis and Immobilization (4 papers). Georges Hirth collaborates with scholars based in Switzerland. Georges Hirth's co-authors include Volker Breu, Kaspar F. Burri, Martine Clozel, Werner Neidhart, Jean‐Marie Cassal, Gillian A. Gray, Michael Müller, B M Löffler, R. Barner and Marcel Müller and has published in prestigious journals such as Nature, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Georges Hirth

17 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

1994 590 citations Martine Clozel, Volker Breu et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georges Hirth Switzerland	11	849	586	555	252	201	17	1.5k
William J. Chiou United States	23	736 0.9×	1.2k 2.1×	254 0.5×	161 0.6×	197 1.0×	57	2.2k
Werner Neidhart Switzerland	16	887 1.0×	943 1.6×	588 1.1×	270 1.1×	274 1.4×	30	2.2k
Thomas W von Geldern United States	26	458 0.5×	617 1.1×	382 0.7×	152 0.6×	853 4.2×	57	2.1k
Kaspar F. Burri Switzerland	10	825 1.0×	346 0.6×	493 0.9×	249 1.0×	171 0.9×	14	1.3k
Brian Woodward United Kingdom	22	354 0.4×	737 1.3×	403 0.7×	393 1.6×	88 0.4×	64	1.7k
Cynthia L. Sundell United States	12	608 0.7×	658 1.1×	507 0.9×	117 0.5×	62 0.3×	16	1.8k
Henri Ramuz Switzerland	14	583 0.7×	306 0.5×	346 0.6×	206 0.8×	124 0.6×	26	1.0k
Angelo J. Trapani United States	23	448 0.5×	525 0.9×	661 1.2×	139 0.6×	240 1.2×	74	1.6k
Brian D. Dayton United States	22	463 0.5×	650 1.1×	211 0.4×	107 0.4×	244 1.2×	38	1.5k
Ellen G. McMahon United States	23	425 0.5×	781 1.3×	789 1.4×	238 0.9×	160 0.8×	45	2.1k

Countries citing papers authored by Georges Hirth

Since Specialization

Citations

This map shows the geographic impact of Georges Hirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Hirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Hirth more than expected).

Fields of papers citing papers by Georges Hirth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Hirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Hirth. The network helps show where Georges Hirth may publish in the future.

Co-authorship network of co-authors of Georges Hirth

This figure shows the co-authorship network connecting the top 25 collaborators of Georges Hirth. A scholar is included among the top collaborators of Georges Hirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georges Hirth. Georges Hirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Vieira, Eric, Alfred Binggeli, Volker Breu, et al.. (1999). Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorganic & Medicinal Chemistry Letters. 9(10). 1397–1402. 79 indexed citations

Güller, Rolf, Alfred Binggeli, Volker Breu, et al.. (1999). Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 9(10). 1403–1408. 52 indexed citations

Oefner, Christian, Alfred Binggeli, Volker Breu, et al.. (1999). Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?. Chemistry & Biology. 6(3). 127–131. 100 indexed citations

Neidhart, Werner, Volker Breu, Kaspar F. Burri, et al.. (1997). Discovery of Ro 48-5695: A potent mixed endothelin receptor antagonist optimized from bosentan. Bioorganic & Medicinal Chemistry Letters. 7(17). 2223–2228. 26 indexed citations

Breu, Volker, Martine Clozel, Kaspar F. Burri, et al.. (1996). In vitro characterisation of Ro 46‐8443, the first non‐peptide antagonist selective for the endothelin ET_B receptor. FEBS Letters. 383(1-2). 37–41. 31 indexed citations

Neidhart, Werner, Volker Breu, Daniel Bur, et al.. (1996). The Discovery of Nonpeptide Endothelin Receptor Antagonists. Progression towards Bosentan. CHIMIA International Journal for Chemistry. 50(11). 519–519. 22 indexed citations

Clozel, Martine, Volker Breu, Gillian A. Gray, et al.. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 270(1). 228–235. 590 indexed citations breakdown →

Clozel, Martine, Volker Breu, Kaspar F. Burri, et al.. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 365(6448). 759–761. 426 indexed citations

Hirth, Georges & W. Walther. (1986). ChemInform Abstract: Synthesis of the (R)‐ and (S)‐Glycerol Acetonides. Determination of the Optical Purity.. Chemischer Informationsdienst. 17(6). 1 indexed citations

10.

Hirth, Georges & W. Walther. (1985). Synthèse des (R)‐ et (S)‐O‐isopropylidène‐1,2‐glycérols. Détermination de la pureté optique. Helvetica Chimica Acta. 68(7). 1863–1871. 56 indexed citations

11.

Burri, Kaspar F., R. Barner, Jean‐Marie Cassal, et al.. (1985). PAF: From agonists to antagonists by synthesis. Prostaglandins. 30(4). 691–691. 9 indexed citations

12.

Hirth, Georges, et al.. (1984). ChemInform Abstract: SYNTHESIS OF GLYCERYLETHERPHOSPHATIDES. PART 2. PREPARATION OF 2‐O‐ACETYL‐1‐O‐((Z)‐9‐OCTADECENYL)‐SN‐GLYCERYL‐3‐PHOSPHORYLCHOLINE (′OLEYL‐PAF′), OF ITS ENANTIOMER AND SOME ANALOGOUS, UNSATURATED COMPOUNDS. Chemischer Informationsdienst. 15(1). 2 indexed citations

13.

Hirth, Georges, et al.. (1983). Synthese von Glycerylätherphosphatiden 2. Mitteilung Herstellung von 2‐O‐Acetyl‐1‐O‐[(Z)‐9‐octadecenyl] ‐sn‐glyceryl‐3‐phosphorylcholin («Oleyl‐PAF»), des Enantiomeren sowie einiger analoger, ungesättigter Verbindungen. Helvetica Chimica Acta. 66(4). 1210–1240. 37 indexed citations

14.

Hirth, Georges & R. Barner. (1982). Synthese von Glycerylätherphosphatiden 1. Mitteilung Herstellung von 1‐O‐Octadecyl‐2‐O‐acetyl‐sn‐glyceryl‐3‐phosphorylcholin¹ (‘Platelet Activating Factor’), des Enantiomeren sowie einiger analoger Verbindungen. Helvetica Chimica Acta. 65(3). 1059–1084. 87 indexed citations

15.

Hirth, Georges, et al.. (1982). Stereoselektive Totalsynthese von natürlichem Phytol und Phytolderivaten und deren Verwendung zur Herstellung von natürlichem Vitamin K₁. Helvetica Chimica Acta. 65(3). 684–702. 8 indexed citations

16.

Hirth, Georges & R. Barner. (1982). ChemInform Abstract: SYNTHESIS OF GLYCERYL ETHER PHOSPHATIDES. PART 1. PREPARATION OF 1‐O‐OCTADECYL‐2‐O‐ACETYL‐SN‐GLYCERYL‐3‐PHOSPHORYLCHOLINE (′PLATELET ACTIVATING FACTOR′), ITS ENANTIOMERS AND SOME ANALOGOUS COMPOUNDS. Chemischer Informationsdienst. 13(36). 1 indexed citations

17.

Baumgartner, HR, et al.. (1981). Aggregating Activity Of Structural Analogues Of Platelet Activating Factor (PAF): High Stereospecificity. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact